The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 37, No. 3, pp. 395-397. DOI 10.1345/aph.1C273
© 2003 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Köklü, S.
Right arrow Articles by Altiparmak, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Köklü, S.
Right arrow Articles by Altiparmak, E.

Recurrent Cholestasis Due to Ampicillin

Seyfettin Köklü, MD

Research Fellow, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey

Osman Yüksel, MD

Research Fellow, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Levent Filik, MD

Research Fellow, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Oguz Üsküdar, MD

Research Fellow, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Kadri Altundag, MD

Associate Professor, Department of Medical Oncology, Hacettepe University Institute of Oncology, Ankara

Emin Altiparmak, MD

Instructor, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Reprints: Seyfettin Köklü MD, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital, Orman Genel Müdürlügü Lojmanlari, 86 / 3, 06560-Gazi, Ankara, Turkey, FAX 90-312-3242009, E-mail gskoklu{at}yahoo.com

OBJECTIVE: To present a single case of ampicillin-induced recurrent cholestasis and a literature review.

CASE SUMMARY: A 23-year-old man was hospitalized due to recurrent and self-limited cholestatic symptoms. He had used ampicillin before each cholestatic attack. He became well clinically and biochemically each time after cessation of the drug. One year after his recovery and discontinuance of ampicillin, the patient has had no recurrence of cholestasis. An objective causality assessment revealed that the adverse drug reaction was probable.

DISCUSSION: Ampicillin-related hepatotoxicity is very rare, with injury being mainly hepatocellular. To our knowledge, there is only 1 case report in the literature referring to chronic cholestatic-type hepatotoxicity related to ampicillin.

CONCLUSIONS: Ampicillin, which is one of the most widely used antibiotics, may cause recurrent cholestatic hepatitis. Clinicians should be aware of this adverse effect, and it should be kept in mind during diagnostic workup of liver injury.

Key Words: ampicillin, cholestatic hepatitis

Published Online, January 27, 2003. www.theannals.com, DOI 10.1345/aph.1C273


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
S. Koklu, A. S Koksal, M. Asil, H. Kiyici, S. Coban, and M. Arhan
Probable Sulbactam/Ampicillin-Associated Prolonged Cholestasis
Ann. Pharmacother., December 1, 2004; 38(12): 2055 - 2058.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. Koklu, O. Yuksel, O. F. Yolcu, M. Arhan, and E. Altiparmak
Cholestatic attack due to ampicillin and cross-reactivity to cefuroxime
Ann. Pharmacother., September 1, 2004; 38(9): 1539 - 1540.
[Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2003 by Harvey Whitney Books Company.